Insider · CIK 0001787307

Dahms Bradford D.

Reports to the SEC for 3 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001787307

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-12	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+227K sh	—	—	226,875
2026-02-12	JBIOJade Biosciences, Inc.A Award	Chief Financial Officer	AAward	+37.8K sh	—	—	37,813
2025-07-14	JBIOJade Biosciences, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+526K sh	—	—	526,000
2024-02-14	Theseus Pharmaceuticals, Inc.U Disposition from Tender	President and CFO	UDisposition from Tender	−8,150.225 sh	—	—	0
2024-02-14	Theseus Pharmaceuticals, Inc.Restricted Stock UnitsD Disposition to Issuer	President and CFO	DDisposition to Issuer	−17.5K sh	—	—	0
2024-02-14	Theseus Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	President and CFO	DDisposition to Issuer	−332K sh	—	—	0
2023-03-01	Theseus Pharmaceuticals, Inc.Restricted Stock UnitsA Award	President and CFO	AAward	+17.5K sh	—	—	17,500
2023-02-17	Theseus Pharmaceuticals, Inc.Stock Option (right to buy)A Award	President and CFO	AAward	+105K sh	—	—	105,000
2022-11-30	Theseus Pharmaceuticals, Inc.P Purchase	President and CFO	PPurchase	+1,502.189 sh	$6.66	+$10K	6,142.225
2022-02-18	Theseus Pharmaceuticals, Inc.Stock Option (right to buy)A Award	President and CFO	AAward	+150K sh	—	—	150,000
2021-12-21	Theseus Pharmaceuticals, Inc.P Purchase	President and CFO	PPurchase	+1,970.036 sh	$10.15	+$20K	1,970.036
2021-01-04	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+230K sh	—	—	230,000
2021-01-04	RNACCartesian Therapeutics, Inc.A Award	Chief Financial Officer	AAward	+38K sh	—	—	38,000
2020-07-01	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2020-01-02	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+140K sh	—	—	140,000
2019-09-03	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+400K sh	—	—	400,000

Recent filings

Accepted (ET)
Feb 134
Dahms Bradford D.0001193125-26-052056
SEC(opens sec.gov)
Jul 144
Dahms Bradford D.0000950170-25-095668
SEC(opens sec.gov)
Feb 144
Dahms Bradford D.0001104659-24-023551
SEC(opens sec.gov)
Mar 24
Dahms Bradford D.0001104659-23-027624
SEC(opens sec.gov)
Feb 214
Dahms Bradford D.0001104659-23-023506
SEC(opens sec.gov)
Dec 14
Dahms Bradford D.0001104659-22-123686
SEC(opens sec.gov)
Feb 234
Dahms Bradford D.0000899243-22-007498
SEC(opens sec.gov)
Dec 224
Dahms Bradford D.0000899243-21-049427
SEC(opens sec.gov)
Jan 64
Dahms Bradford D.0001453687-21-000015
SEC(opens sec.gov)
Jul 64
Dahms Bradford D.0001104659-20-081211
SEC(opens sec.gov)
Jan 64
Dahms Bradford D.0001453687-20-000010
SEC(opens sec.gov)
Sep 54
Dahms Bradford D.0001453687-19-000133
SEC(opens sec.gov)

Companies

Address

C/O JADE BIOSCIENCES, INC. 221 CRESCENT ST., BLDG. 23, STE. 105

WALTHAM, MA, 02453